The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.

Henrik Ekedahl; Helena Cirenajwis; Katja Harbst; Ana Carneiro; Kari Nielsen; Håkan Olsson; L Lundgren; Christian Ingvar; Gunilla Jönsson

doi:10.1111/bjd.12504

The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.

Henrik Ekedahl, Helena Cirenajwis, Katja Harbst, Ana Carneiro, Kari Nielsen, Håkan Olsson, L Lundgren, Christian Ingvar, Gunilla Jönsson

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Sammanfattning

BRAF and NRAS mutations are frequently found in melanoma tumours and recently developed BRAF targeted therapies demonstrate significant clinical benefit.

Originalspråk	engelska
Sidor (från-till)	1049-1055
Tidskrift	British Journal of Dermatology
Volym	169
Nummer	5
DOI	https://doi.org/10.1111/bjd.12504
Status	Published - 2013

Ämnesklassifikation (UKÄ)

Dermatologi och venereologi

Tillgång till dokument

10.1111/bjd.12504

http://www.ncbi.nlm.nih.gov/pubmed/23855428?dopt=Abstract

1 Doktorsavhandling (sammanläggning)

Clinical aspects of molecular profiles in metastatic malignant melanoma
Ekedahl, H., 2017, Lund: Lund University: Faculty of Medicine. 83 s.
Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)

Öppen tillgång
Fil

Citera det här

@article{9a26400c9a644bc58990e520c9671ae9,

title = "The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.",

abstract = "BRAF and NRAS mutations are frequently found in melanoma tumours and recently developed BRAF targeted therapies demonstrate significant clinical benefit.",

author = "Henrik Ekedahl and Helena Cirenajwis and Katja Harbst and Ana Carneiro and Kari Nielsen and H{\aa}kan Olsson and L Lundgren and Christian Ingvar and Gunilla J{\"o}nsson",

year = "2013",

doi = "10.1111/bjd.12504",

language = "English",

volume = "169",

pages = "1049--1055",

journal = "British Journal of Dermatology",

issn = "1365-2133",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.

AU - Ekedahl, Henrik

AU - Cirenajwis, Helena

AU - Harbst, Katja

AU - Carneiro, Ana

AU - Nielsen, Kari

AU - Olsson, Håkan

AU - Lundgren, L

AU - Ingvar, Christian

AU - Jönsson, Gunilla

PY - 2013

Y1 - 2013

N2 - BRAF and NRAS mutations are frequently found in melanoma tumours and recently developed BRAF targeted therapies demonstrate significant clinical benefit.

AB - BRAF and NRAS mutations are frequently found in melanoma tumours and recently developed BRAF targeted therapies demonstrate significant clinical benefit.

U2 - 10.1111/bjd.12504

DO - 10.1111/bjd.12504

M3 - Article

C2 - 23855428

SN - 1365-2133

VL - 169

SP - 1049

EP - 1055

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 5

ER -

The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.

Sammanfattning

Ämnesklassifikation (UKÄ)

Tillgång till dokument

Fingeravtryck

Forskningsoutput

Clinical aspects of molecular profiles in metastatic malignant melanoma

Citera det här